Literature DB >> 9462376

Surgical strategies for carcinoma of the hepatic duct confluence.

Y Ogura1, Y Kawarada.   

Abstract

BACKGROUND: This study was conducted to clarify the clinicopathological factors influencing appropriate surgical strategy and survival in patients with carcinoma of the hepatic duct confluence.
METHODS: A total of 66 patients who underwent local resection of the bile duct with (n = 44) and without (n = 22) hepatectomy were reviewed retrospectively.
RESULTS: Fifteen of the 44 patients who had hepatectomy and two of the 22 who did not suffered major postoperative complications (P < 0.05). As the pT category rose, the incidence of microscopic tumour extension increased significantly. Invasion at the surgical margins was more frequent in the patients who did not have hepatectomy than in those who did. Extramural tumour extension was found in 23 of 28 patients, and its prevalence was higher in the hepatic direction than the duodenal direction. Cancer invasion to the caudate lobe was found in nine of 21 patients. Thirty of 44 patients who underwent hepatectomy had a curative resection compared with six of 22 who did not have hepatectomy (P < 0.01). The cumulative survival rates after curative resection were significantly higher than after non-curative resection (P < 0.01).
CONCLUSION: Hepatectomy with caudate lobectomy improves the curability and prognosis because these tumours frequently invade the surgical margins. However, operative morbidity is higher with this procedure.

Entities:  

Mesh:

Year:  1998        PMID: 9462376     DOI: 10.1046/j.1365-2168.1998.00532.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  17 in total

1.  Changing trends of surgical treatment of hilar bile duct cancer: clinical and experimental perspectives.

Authors:  Zhi-Qiang Huang; Ning-Xin Zhou; Da-Dong Wang; Jian-Guo Lu; Ming-Yi Chen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 2.  Biliary tract surgery.

Authors:  S A Ahrendt
Journal:  Curr Gastroenterol Rep       Date:  1999-04

3.  Liver transplantation is not indicated for cholangiocarcinoma.

Authors:  C Wright Pinson; Derek E Moore
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

4.  Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Simone Conci; Alessandro Valdegamberi; Marco Sandri; Calogero Iacono
Journal:  HPB (Oxford)       Date:  2011-01-28       Impact factor: 3.647

5.  Impact of lymph node micrometastasis in hilar bile duct carcinoma patients.

Authors:  Kentaro Taniguchi; Taku Iida; Tomohide Hori; Shintaro Yagi; Hiroshi Imai; Taizo Shiraishi; Shinji Uemoto
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

6.  Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection.

Authors:  Y Kitagawa; M Nagino; J Kamiya; K Uesaka; T Sano; H Yamamoto; N Hayakawa; Y Nimura
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

7.  Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies.

Authors:  Yoshifumi Kawarada; Bidhan C Das; Tatsushi Naganuma; Masami Tabata; Hiroki Taoka
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

8.  Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization.

Authors:  Seiji Kawasaki; Hiroshi Imamura; Akira Kobayashi; Terumasa Noike; Shiro Miwa; Shin-ichi Miyagawa
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

9.  Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection?

Authors:  Kevin Tri Nguyen; Jennifer Steel; Tsafrir Vanounou; Allan Tsung; J Wallis Marsh; David A Geller; T Clark Gamblin
Journal:  Ann Surg Oncol       Date:  2009-09-23       Impact factor: 5.344

Review 10.  Current surgical treatment for bile duct cancer.

Authors:  Yasuji Seyama; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.